PharmiWeb.com - Global Pharma News & Resources
26-Feb-2021

US Point-of-Care Diagnostics Market 2021, Research Analysis Report Growth at CAGR Value, Industry Share, Key Company Profiles, and Research Development Report to 2027

Pune, Maharashtra, India, February 26 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Point-of-Care Diagnostics Market is valued at USD 22688.6 Million in 2018 and expected to reach USD 46308.9 Million by 2025 with the CAGR of 10.73% over the forecast period.

Point-of-care testing diagnostics (POCD) refers to the rapid detection of diseases near to patient, which provides an appropriate diagnosis, monitoring and management. Potentially it offers fast medical treatment to improve health outcome of patients to cure medical conditions. Consequently, POCD can be integrated with healthcare system to provide laboratory testing outside of the main laboratory with dedicated clinical settings. Recent advancements in point of care diagnostics have made testing easier that can be performed by moderately trained staff and require less human interaction. For example, sensor technologies is used to perform rapid testing of blood samples for many critical assays, where biosensors are used for drug screening, appropriate measurement of blood cells, detection of cardiac markers and glucose testing.

Get Sample of This Report@ https://industrystatsreport.com/Request/Sample?ResearchPostId=243&RequestType=Sample

US Point-of-Care Diagnostics Market report is segmented on the testing, by mode, end-users and by regional & country level. Based upon testing, US point-of-care diagnostics market is segmented as glucose testing, infectious disease, blood gas electrolyte, cardiac biomarker, coagulation, cholesterol, pregnancy, drugs of abuse, urinalysis, and hematology and other. Furthermore, based upon mode, point-of-care diagnostics market is segmented into prescription-based testing and OTC-based testing. Based on end-users, market is classified into hospitals and clinics, homecare settings and diagnostic centers.

The regions covered in this Point-of-Care Diagnostics market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Point-of-Care Diagnostics market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Point-of-Care Diagnostics Market Report–

Some major key players for US Point-of-Care Diagnostics market are Abbott Laboratories, Becton Dickinson & Co, Bio-Rad Laboratories, Inc, Trinity Biotech, Accubiotech, Quidel, Danaher, F. Hoffmann-La Roche Ltd, Nova Biomedical, Dickinson and Company and Others.

News-

On 6th Sept, 2016, Danaher Corporation announced merger agreement with Cepheid to which Danaher acquired all of the shares of Cepheid Company for USD 53.00 per share in cash to strengthen their presence in the Molecular Diagnostics market.

Rising incidences of chronic diseases such as diabetes, cancer and increasing geriatric population are expected to drive the Point-of-Care Diagnostics Market growth.

Point-of-care diagnostics market is expected to show a high growth owing to the rising demand of home based healthcare devices collectively on account of providing rapid test results for positive health outcome of patients. In addition, in time sensitive medical conditions, POCD devices provide requirements along with cost effective test procedure, timely medical care for ambulatory patients which create the immense demand of these types of medical solutions. Furthermore, patient’s inclination towards early detection of chronic diseases as well as rising geriatric population are also supplementing the demand for point of care diagnostics devices with immediate test results made positive outlook in healthcare delivery. USly, aged population over 60 years was 962 million in 2017; the number of older population is expected to reach around 2.1 billion by 2050. For example, i-STAT System offers most comprehensive testing solutions include cardiac markers, blood gases, lactate, chemistries and electrolytes, coagulation, and hematology. Diabetes covers nearly 67% of POCD market. However, before consideration of implementing any point of care device, regulatory requirements should be performed that arise as a biggest challenge for the further growth of this market. Untapped potential of lab on chip technology will create opportunities for future expansion of POCT market.

North America is expected to dominate the Point-of-Care Diagnostics Market.

North America holds largest share of point of care diagnostics market due to the prevalence of chronic diseases such as diabetes, cancer, heart disease, where high incidences of time sensitive medical condition provides encouragement for the expansion of POCT in this region. In 2016, over 1.7 million of people in the U.S. were needed to have a cancer diagnosis. Moreover, favorable government initiatives related to the development of healthcare infrastructure and widespread manufacturers are present in the U.S. are constantly focusing on research and development to create POCD products with advanced technologies are some of the factors anticipated to foster the growth in this market in this region within the forecast period. In addition, diagnostic tests are implemented about 7 billion times each year in the U.S. The point of care diagnostics market in Asia Pacific region is expected to grow rapidly due to the high demand of unmet medical needs, growing medical awareness and rise in economy of countries like India & China.

Key Benefits for Point-of-Care Diagnostics Market Reports –

US market report covers in depth historical and forecast analysis.

US market research report provides detail information about Market Introduction, Market Summary, US market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

US market report helps to identify opportunities in market place.

US market report covers extensive analysis of emerging trends and competitive landscape.

Point-of-Care Diagnostics Market Segmentation-:

By Testing

Glucose testing

Infectious disease

Blood gas electrolyte

Cardiac biomarker

Coagulation

Cholesterol

Pregnancy

Drugs of abuse

Urinalysis

Hematology

Other

By Mode

Prescription-based Testing

OTC-based Testing

By End-Users

Hospitals and Clinics

Homecare Settings

Diagnostic Centers

By Regional & Country Analysis:

North America

U.S.

Canada

Europe

UK.

France

Germany

Italy

Asia Pacific

China

Japan

India

Southeast Asia

Latin America

Brazil

Mexico

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Table of Content

1. Chapter – Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 

2. Chapter – US Point-of-Care Diagnostics Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. US Point-of-Care Diagnostics Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7.  Point-of-Care Diagnostics Market: Trends
2.8. Porter’s Five Forces Analysis
2.9. Market Attractiveness Analysis 

3. Chapter – US Point-of-Care Diagnostics Market Overview: Quantitative Analysis

4. Chapter – US Point-of-Care Diagnostics Market Analysis: Segmentation By Type

5. Chapter – US Point-of-Care Diagnostics Market Analysis: Segmentation By Application

Continued….

Complete Report Details @ https://industrystatsreport.com/Lifesciences-and-Healthcare/Point-of-Care-Diagnostics-Market/Summary

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44 2038074155 or mail us at sales@brandessenceresearch.com

Website: https://brandessenceresearch.com/

Article: https://businessstatsnews.com

Related Report:

https://www.marketwatch.com/press-release/uk-5g-security-market-2021-to-2027-by-network-type-deployment-mode-organization-size-application-analysis-regional-revenue-top-company-profiles-cagr-values-2021-02-25?tesla=y

https://www.marketwatch.com/press-release/us-bot-mitigation-market-share-current-trends-and-research-development-report-to-2027-2021-02-25?tesla=y

https://www.marketwatch.com/press-release/US-condition-monitoring-sensors-market-2021-share-trends-segmentation-and-forecast-by-2027-2021-02-25?tesla=y

This content has been published by Brandessence Market Research and Consulting Pvt ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.

Editor Details

Last Updated: 26-Feb-2021